Evidence map›Paper›PMID 32494995›Full record

ArticleBiotechnology letters2020

Nanoparticle technology improves in-vitro attachment of cattle (Bos taurus) trophectoderm cells.

Jaewook Chung, Ganesh Sriram, Carol L Keefer

Abstract read
PubMed Publisher
In one paragraph

Article in Biotechnology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Magnetic-Based Human Tissue 3D Cell Culture: A Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jaewook ChungDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, 20742, USA.
Ganesh SriramDepartment of Chemical and Biomolecular Engineering, University of Maryland, College Park, MD, 20742, USA.
Carol L KeeferDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, 20742, USA. ckeefer@umd.edu.ORCID http://orcid.org/0000-0002-7326-7633

Funding

National Institute of Food and Agriculture Award No. 2015-67015-23237.
6 · The paper itself

Abstract

The bovine cell line, cow trophectoderm-1 (CT-1), provides an excellent in-vitro cell culture model to study early embryonic development. Obtaining consistent attachment and outgrowth, however, is difficult because enzymatic disassociation into single cells is detrimental; therefore, CT-1 cells must be passaged in clumps, which do not attach readily to the surface of the dish. We tested whether magnetic nanoparticles, NanoShuttle™-PL, could be used to improve cell attachment and subsequent proliferation of the cattle trophectoderm cell line without altering cellular metabolism or immunofluorescent detection of the lineage marker Caudal Type Homeobox 2 (CDX2). Confluency was achieved more consistently by using the NanoShuttle™-PL system to magnetically force attachment (75-100% of wells) as compared to the control (11%). Moreover, there were no alterations in characteristic morphology, nuclear-localized expression of the trophectoderm marker CDX2, or glycolytic metabolism. By enhancing attachment, magnetic nanoparticles improved culture efficiency and reproducibility in an anchorage-dependent cell line that otherwise was recalcitrant to efficient passaging.

Indexed as

AnimalsCattleCDX2 Transcription FactorCell AdhesionCell Culture TechniquesCell LineCell ProliferationEctodermFemaleGlycolysisMagnetite NanoparticlesPregnancyTrophoblastsCDX2 Transcription FactorMagnetite NanoparticlesAttachmentCDX2Cell cultureMagnetic nanoparticlesTrophectoderm

Identifiers

PMID32494995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.